[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Goodfellow et al., 2000 - Google Patents

Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen‐induced arthritis

Goodfellow et al., 2000

View HTML
Document ID
9395651943900507078
Author
Goodfellow R
Williams A
Levin J
Williams B
Morgan B
Publication year
Publication venue
Clinical & Experimental Immunology

External Links

Snippet

We set out to determine whether inhibition of complement using sCR1 could influence the development and progression of collagen arthritis in the Lewis rat. Collagen arthritis was successfully established in the Lewis rat, using a novel immunization schedule. In separate …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Goodfellow et al. Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen‐induced arthritis
KR100234678B1 (en) Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier.
Meltzer et al. Cryoglobulinemia—a clinical and laboratory study: II. Cryoglobulins with rheumatoid factor activity
Rankin et al. The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis
Thompson et al. Autoimmune reactions to heat‐shock proteins in pristane‐induced arthritis
Deodhar et al. Production of antirenin to homologous renin and its effect on experimental renal hypertension
Cremer et al. Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen.
Winn et al. Acute destruction by humoral antibody of rat skin grafted to mice: the role of complement and polymorphonuclear leukocytes
Prendergast et al. Invertebrate protein simulating mediators of delayed hypersensitivity
KR20040018370A (en) Use of hmg fragment as anti-inflammatory agents
IL194987A (en) Use of pif peptide in the manufacture of a medicament for modulating the immune system
Papadopoulou et al. Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era
EA029436B1 (en) Combination pharmaceutical composition for treating multiple sclerosis and infectious diseases followed by neurotoxic disorders, and methods of treating said diseases
JP3971797B2 (en) Method for treating inflammatory joint diseases
Füchtenbusch et al. Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.
Clinton et al. Cellular events during the induction of experimental thyroiditis in the rabbit
Arinoviche et al. Comparison of the effects of two cytotoxic drugs and of antilymphocytic serum on immune and non-immune inflammation in experimental animals.
Lachmann Lupus and desoxyribonuclease
Phadke et al. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.
Waldum et al. Serum group I pepsinogens during prolonged infusion of pentagastrin and secretin in man
Kleinau et al. A monoclonal antibody to the mycobacterial 65kDa heat shock protein (ML 30) binds to cells in normal and arthritic joints of rats
Altman et al. The effects of a partially purified fraction of an ant venom in rheumatoid arthritis
Kövary et al. Paraproteinaemia in erythema elevatum diutinum
EP3381934B1 (en) Protein for neutralizing programmed necrocytosis promotion antibody, and application of protein
Mogensen et al. Studies on mechanisms of proteinuria using amino-acid-induced inhibition of tubular reabsorption in normal and diabetic man